NCT00004186View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

etoposide

DRUG

ifosfamide

DRUG

topotecan hydrochloride

RADIATION

radiation therapy

Trial Locations (1)

35294

University of Alabama Comprehensive Cancer Center, Birmingham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00004186 - Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter